XML 35 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2021
Stock-Based Compensation  
Schedule of fair value assumptions

September 30, 

September 30, 

2021

2020

Risk-free interest rate

    

0.63%

    

*

Expected term (in years)

5.98

*

Expected volatility

77.07%

*

Expected dividend yield

 

 

*

Schedule of stock option activity

Weighted

Weighted

Average

Average

Remaining

Number of

Exercise

Contractual

Aggregate

Shares

Price

Term

Intrinsic Value

(in years)

(in thousands)

Outstanding as of December 31, 2020

    

4,776,908

    

$

10.83

    

9.67

    

$

177,962

Granted

1,031,733

35.88

9.31

Exercised(1)

(156,385)

3.38

Forfeited

(87,668)

22.39

Outstanding as of September 30, 2021(2)

5,564,588

$

15.50

9.03

$

71,759

Options vested and exercisable as of September 30, 2021

1,053,721

$

7.38

8.57

$

21,315

Options expected to vest as of September 30, 2021

4,510,867

$

17.39

9.14

$

54,999

(1)Exercised amount includes vesting of early exercised options.
(2)Balance as of September 30, 2021 includes 53,588 unvested early exercised stock options.
Summary of restricted stock activity

Number of Shares

Grant Date Fair Value

Unvested restricted stock as of December 31, 2020

    

735,294

    

$

2.40

Granted

Vested

(192,790)

2.40

Forfeited

Unvested restricted stock as of September 30, 2021

 

542,504

$

2.40

Schedule of stock-based compensation expense

Three Months Ended September 30, 

Nine Months Ended September 30, 

2021

2020

2021

2020

Research and development

    

$

2,405

    

$

392

    

$

6,427

    

$

495

General and administrative

 

 

1,752

190

 

 

4,859

241

Total

 

$

4,157

$

582

 

$

11,286

$

736